(IN BRIEF) Merck, a prominent science and technology company, announces a €14 million expansion of its M LabTM Collaboration Center…
(IN BRIEF) E. Merck KG, representing the Merck family's interests in Merck KGaA, has disclosed the results of its regular…
(IN BRIEF) Merck, a leading science and technology company, has inaugurated the Merck Digital Hub in Singapore, its first digital…
(IN BRIEF) Merck has completed the second phase of its new €29 million Biologics Testing Center in China, adding 1,500…
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This…
(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in…
(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society…
(IN BRIEF) Merck has presented new data on evobrutinib, an investigational BTK inhibitor, at the 9th Joint ECTRIMS-ACTRIMS congress. The…
(IN BRIEF) Merck, a prominent science and technology company, has revealed new findings from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study…
(IN BRIEF) Merck, a prominent science and technology company, has entered into a collaboration with the United Nations’ Global Initiative…
(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI…
(IN BRIEF) Merck will showcase innovative ideas and new products for the paint and coatings industry at the European Coatings…
(IN BRIEF) Merck and Intel have signed a memorandum of understanding to invest in a new academic research program aimed…
(PRESS RELEASE) DARMSTADT, 24-Jan-2022 — /EuropaWire/ — Merck (ETR: MRK), a German multinational leading science and technology company in healthcare,…
New product specifically for the needs of aging skin Essential calcium improves overall skin integrity Halal-certified blend of 100% of…
(PRESS RELEASE) DARMSTADT, 6-Aug-2021 — /EuropaWire/ — The Merck Group (ETR: MRK), a German multinational science and technology company, has…
Innovation Center project of Merck aims to develop smart neurostimulators for targeted treatment of chronic diseases Second collaboration within the…
Closing of sale to Procter & Gamble at a cash purchase price of € 3.4 billion completed Successful completion allows Merck to…
Merck today (12 NOV 2018) signed an agreement with the Guangzhou Development District on innovation development in Southern China. DARMSTADT,…
Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent…
Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for…
First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which…
Toepfer joins from Metro Group, where he served as Head of the IT service company Metro Systems DARMSTADT, 26-Jan-2018 —…
Not intended for US/Canada based media The presentation of the grants coincides with the 10th International Meeting of Pediatric Endocrinology The…
Relocations to drive focus on sites in Darmstadt, Schnelldorf (Germany), Buchs (Switzerland) and Molsheim (France) Sequential implementation until the end…
Preliminary research indicates most MS carers are between the ages of 18-34, the prime of their lives Largest global MS…
Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo DARMSTADT, 02-May-2017 — /EuropaWire/…
Data presented at the 2016 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting (Abstract Number: 12L) DARMSTADT,…
First Phase III trial evaluating the addition of an immune checkpoint inhibitor to standard of care in first-line ovarian cancer…
Investment reflects company’s commitment to innovation in fertility research Globally, six projects receive funding from this grant cycle Darmstadt, Germany,…
Merck obtains global marketing and commercialization rights for the innovative Progyny Eeva® software offering, aiming to provide customers worldwide with…
Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, announced that the Weizmann Institute,…
Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, today extended the partnership with…
BRUSSELS, 18-6-2015 — /EuropaWire/ — The European Commission has approved the proposed acquisition of Sigma-Aldrich by Merck under the EU…
• Darmstadt-based company holds global rights to the name Merck with exception of the U.S. and Canada Darmstadt, Germany, 7-5-2014…
• The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation • Study…